---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-000788"
form_type: "8-K"
ticker: "MAIA"
cik: "0001878313"
company_name: "MAIA Biotechnology, Inc."
filed_at: "2025-03-26T23:59:59+00:00"
generated_at: "2026-05-24T05:15:22.243153+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# MAIA Biotechnology reduces ATM offering capacity from $30M to $11.2M

## Summary
- Maximum aggregate offering price reduced from $30M to $11.2M under ATM with H.C. Wainwright.
- Prior sales: $6.29M in last 12 months, $11.63M total under the agreement.
- Prospectus supplement dated March 26, 2025 filed for the $11.2M offering.
- No reason given for reduction; company continues at-the-market program.

## SEC filing metadata
- accession: 0001641172-25-000788
- form_type: 8-K
- ticker: MAIA
- cik: 0001878313
- company_name: MAIA Biotechnology, Inc.
- filed_at: 2025-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1878313/000164117225000788/0001641172-25-000788-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1878313/000164117225000788/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-000788
- JSON: https://secwatch.observer/filing/0001641172-25-000788.json
- Plain text: https://secwatch.observer/filing/0001641172-25-000788.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.